BMS-795311

N/A

Report date: 2024/08/16 10:52:17
NME

Base Information

Drug NameBMS-795311
Drug Alias NameBMS-795311
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholesteryl ester transfer protein inhibitors
TargetsCholesteryl ester transfer protein
Therapy Area/IndicationsAtherosclerosisCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb CompanySimcere Pharmaceutical Group Ltd
Inactive CompaniesN/A
Active IndicationsAtherosclerosisCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A